02.04.2008 12:01:00

Cutera Announces Physician Researchers on Podium at The ASLMS Annual Meeting

Cutera, Inc.® (Nasdaq:CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today announced physician researchers will present their clinical findings on Cutera systems at the 28th annual conference for the American Society for Laser Medicine & Surgery (ASLMS), April 2 - 6, 2008. Presentation and poster topics include clinical outcomes using Pearl, a minimally ablative procedure for renewing the skin surface; LimeLight for treating facial vascular and pigmented lesions; ProWave 770 for hair reduction; and Laser Genesis for improving skin tone and texture. Clinical studies accepted for presentation include:     -- Roy Geronemus, MD, Anne Chapas, MD: April 4, 2008 at 2:36 p.m. - 2:41 p.m. "Treatment of Telangiectasia and Solar Lentigines Using a Novel Programmable Flashlamp Device" (LimeLight)   -- Barry DiBernardo, MD: April 5, 2008 at 2:01 p.m. - 2:06 p.m. "Assessment of the Impact of High-Fluence, High-Overlap Settings on Full Face Treatments with the 2,790 nm Pearl YSGG Laser"   -- E. Victor Ross, MD: April 5, 2008 at 2:07 p.m. - 2:12 p.m. "YSGG Laser in Facial Rejuvenation" (Pearl)   -- Jacqueline Calkin, MD: April 6, 2008 at 10:36 a.m. - 10:41 a.m. "Permanent Hair Reduction Using a Programmable Wavelength Infrared Flashlamp Device" (ProWave)   Clinical studies accepted for poster presentations include:   -- Takahiro Fujimoto, MD. Ph.D.: "Skin Resurfacing Utilizing a 2.79 um YSGG Laser for Asian Patients " (Pearl)   -- Kei Negishi, MD: "A Pilot Study Using a Novel 2790 nm YSGG Laser for Asian Skin" (Pearl)   -- Maritza I. Perez, MD, Rebecca Lu, MD: "300-Microsecond 1064nm Nd:YAG Laser in the Treatment of Hypertrophic Scars and Keloids" (Laser Genesis)   -- David M. Verbelyi, MD: "Skin Resurfacing Using a Novel 2790 nm YSGG Laser" (Pearl) About Cutera, Inc. Brisbane, California-based Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Cutera Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Cutera Inc. 0,45 3,91% Cutera Inc.

Indizes in diesem Artikel

NASDAQ Comp. 19 218,17 0,83%